Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 36,294 | N/A |
| Receivables | 3,293 | N/A |
| Inventories | 16,441 | N/A |
| Income taxes - deferred | 1,989 | N/A |
| TOTAL | $59,116 | $N/A |
| Non-Current Assets | ||
| PPE Net | 30,645 | N/A |
| Other Non-Current Assets | 10,571 | 0 |
| TOTAL | $41,216 | $N/A |
| Total Assets | $100,332 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 902 | N/A |
| Accounts payable and accrued liabilities | 10,425 | 0 |
| Accrued Expenses | 8,786 | N/A |
| TOTAL | $30,093 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 10,502 | N/A |
| Deferred Revenues | 7,340 | N/A |
| TOTAL | $10,502 | $N/A |
| Total Liabilities | $40,595 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 22 | N/A |
| Retained earnings | 25,396 | N/A |
| Other shareholders' equity | -276 | 0 |
| TOTAL | $59,737 | $N/A |
| Total Liabilities And Equity | $100,332 | $0 |